Loading briefing details...
News Brief
By: PointLine Media Research & Editorial Team
Category:Business,Health,Industry,Lifestyle,Sports
August 26, 2026
This study is a milestone for functional nutrition, shifting the focus from isolated extracts to whole-fruit benefits. By validating soursop's efficacy in a human trial, it bridges the gap between traditional botanical knowledge and modern clinical science, setting a new standard for how tropical superfruits are evaluated for health.
A recent randomized controlled trial published in the Journal of Human Hypertension provides compelling clinical evidence regarding the health benefits of soursop, also known as graviola. Researchers investigated 143 adults with prehypertension over a 12-week period, finding that consistent consumption of 100 grams of soursop twice daily led to significant improvements in blood pressure markers. Participants experienced a notable reduction in both systolic and diastolic pressure, highlighting the fruit's potential as a functional dietary addition.
Beyond cardiovascular health, the study observed positive impacts on serum uric acid levels. Elevated uric acid is frequently linked to joint inflammation and gout, making this discovery a significant area for future metabolic research. Unlike previous laboratory or animal-based studies, this trial utilized human participants, offering a more direct insight into how the whole fruit interacts with human physiology and metabolic pathways.
As consumer interest in whole-food nutrition and tropical superfruits grows, brands like SOPREME are working to bring authentic, minimally processed soursop to the global market. While this research does not claim soursop replaces medical treatment, it reinforces the value of incorporating nutrient-dense, plant-based foods into a health-conscious lifestyle. These findings underscore the importance of preserving the natural integrity of superfruits to maximize their potential health benefits.